FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to the pharmaceutical industry and medicine. What is presented is using treo-3-phenylglutamic acid dimethyl ester hydrochloride of the following structural formula: as an agent possessing cardioprotective properties under stress stimulation.
EFFECT: treo-3-phenylglutamic acid dimethyl ester hydrochloride possesses the high cardioprotective activity.
8 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT POSSESSING CARDIOPROTECTIVE, ANTIPLATELET, ANTICOAGULANT AND MEMBRANE-PROTECTIVE PROPERTIES UNDER STRESS STIMULATION | 2013 |
|
RU2531080C1 |
AGENT HAVING CARDIOTONIC ACTIVITY | 2012 |
|
RU2521213C1 |
PLANT-DERIVED AGENT WITH CARDIOTONIC ACTIVITY IN CHRONIC HEART FAILURE | 2017 |
|
RU2654706C1 |
ANTIDEPRESSANT, ANXIOLYTIC, NEUROPROTECTIVE AND IMMUNOSTIMULATING AGENT | 2010 |
|
RU2429834C1 |
ETHYLIDENE HYDRAZIDE OF 2-[6-METHYL-1-(THIETHAN-3-YL)URACYL-3-YL]ACETIC ACID, DEMONSTRATING HYPOTENSIVE ACTIVITY | 2013 |
|
RU2539301C1 |
5-POTASSIUM HYDROXINICOTINATE WITH CARDIOPROTECTIVE ACTIVITY | 2017 |
|
RU2640580C1 |
METHOD OF CORRECTING AGGRESSIVE BEHAVIOR CAUSED BY CHRONIC MODERATE STRESS | 2019 |
|
RU2714934C1 |
METHOD OF CARDIOPROTECTIVE ACTIVITY ESTIMATION OF PHARMACOLOGICAL FACILITIES | 2017 |
|
RU2643104C1 |
METHOD FOR PREVENTING AND TREATING MYOCARDIAL ISCHEMIA | 2002 |
|
RU2241463C2 |
AGENT POSSESSING ENDOTHELIUM PROTECTIVE EFFECT IN CONDITIONS OF EXPERIMENTAL DIABETES MELLITUS AND CEREBRAL BLOOD CIRCULATION DISORDER | 2015 |
|
RU2601622C1 |
Authors
Dates
2014-10-20—Published
2013-10-24—Filed